You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Attention Score in Context
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
Orphanet Journal of Rare Diseases, August 2019
V. Vanhoorne, E. Peeters, I. Van Tongelen, K. Boussery, E. Wynendaele, B. De Spiegeleer, J. P. Remon, C. Vervaet
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Practitioners (doctors, other healthcare professionals)||1||50%|
|Members of the public||1||50%|
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Doctoral Student||3||6%|
|Student > Bachelor||2||4%|
|Readers by discipline||Count||As %|
|Pharmacology, Toxicology and Pharmaceutical Science||11||23%|
|Business, Management and Accounting||1||2%|
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
of 23,163,378 outputs
Outputs from Orphanet Journal of Rare Diseases
of 2,654 outputs
Outputs of similar age
of 346,880 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
of 51 outputs
Altmetric has tracked 23,163,378 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,654 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,880 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.